EU Launches Campaign to Attract Scientists from US
Summary:
Europe is allocating €500 million to lure researchers amid concerns about US science policy. France adds €100 million separately, as leaders emphasize scientific freedom and long-term research support.
FDA Appoints Controversial Critic as New CBER Director
Summary:
Vinay Prasad, a vocal critic of COVID mandates and accelerated cancer drug approvals, becomes FDA’s biologics chief, sparking biotech market concerns and raising questions about future vaccine and drug approval policies.
Market Uncertainty Stalls Biotech Deals Amid Trump’s Return
Summary:
Political uncertainty and market volatility under Trump’s administration are freezing pharmaceutical M&A, with buyers hesitant to commit while valuation gaps widen. Smaller deals may proceed, but billion-dollar acquisitions face months-long delays.
NIH Creates New Office to Reduce Animal Testing in Research
Summary:
Under new director Bhattacharya, NIH launches Office of Research Innovation to coordinate animal-free research methods like organoids and computational modeling, promising annual spending reports while drawing mixed reactions from advocacy groups.
Scientists Sound Alarm on Vanishing Research Data
Summary:
Research repositories are increasingly at risk of shutting down, with a study showing 191 repositories closed and 90 losing data access. Experts urge contingency networks, distributed preservation systems, and proper archiving services while noting funding disparities between wealthy and smaller publishers.
